NIH-funded research NIH-funded research

Community Engagement and Outreach Core (CEO) for Translational Health in Kentucky

Official title: Community Engagement and Outreach (CEO) Core

Funded at University of Louisville · NIH-11382439 · Data updated 2026-11-12

A program to strengthen community partnerships and researcher collaboration so people in Kentucky can participate in and benefit from clinical and translational research on chronic disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Louisville
NIH-funded
Lab location1 site (Louisville, United States)
Project startJuly 10, 2024
Project endJune 30, 2029
Funding year2026
Award (this year)$423,349
NIH project number5P20GM155899-03
Project IDNIH-11382439 on NIH RePORTER

Who could benefit from this research

Could help

Residents with chronic diseases in urban Louisville or the Owensboro area who are willing to participate in CBPR processes and community-engaged research activities.

Less likely to help

Some individuals may not directly benefit if they are not engaged in the community collaboration process or if research topics do not align with their needs.

What this research studies

This grant funds the Louisville Clinical and Translational Research Center’s Community Engagement and Outreach Core to build relationships between communities and researchers. It focuses on health literacy, two-way communication, and community-based participatory research to address chronic diseases in urban Louisville and rural Owensboro-area counties. The goal is to empower residents and researchers to work together across all phases of research, improving access and participation. The initiative will leverage existing resources to expand workforce, infrastructure, and community input for future translational efforts.

Why it matters

Potential benefit: It could lead to more responsive research and better health outcomes for people with chronic diseases in Kentucky.

How similar studies have gone: CBPR and community-engaged translational efforts have shown promise in improving research relevance and health literacy in diverse communities.

Where this research is happening

  • University of Louisville
    Louisville, United States
    Active

Researchers

  • Principal investigator: Dunn, Kelli Matheson Bullard — University of Louisville
  • Study coordinator: Dunn, Kelli Matheson Bullard

Related research

Other NIH-funded projects on the same topics.

  • Gastric rhythm map to understand stomach problems using a new noninvasive tool

    A new noninvasive body surface mapping method is being tested to see if abnormal stomach electrical rhythms explain chronic stomach problems like functional dyspepsia and persistent nausea.

    NIH research University of Louisville · Louisville, United States · NIH-11611507

  • Novel antivirals for alphavirus arthritis

    A research team is refining a promising antiviral compound to treat alphavirus infections that cause arthritis, with a focus on Chikungunya and related viruses.

    NIH research University of Louisville · Louisville, United States · NIH-11609180

  • Linking heavy metal exposure to a tougher breast cancer type (TNBC)

    Aimed at understanding how heavy metals like cadmium might trigger a dangerous breast cancer type (TNBC) in people, especially those with BRCA1 risk, to identify possible future treatment strategies.

    NIH research University of Louisville · Louisville, United States · NIH-11567535

  • Cardiac safety of flavored e-cigarette aerosols in adults

    A pharmacist or clinician would test how inhaling flavored e-cigarette aerosols affects heart rhythm in adults to see if flavors raise the risk of heart problems.

    NIH research University of Louisville · Louisville, United States · NIH-11541950

  • Biomedical Research Facilities to Expand Precision Medicine in Kentucky

    A large NIH grant aims to renovate and expand a shared precision medicine center in Kentucky to speed up research that could improve health for people in Appalachia and surrounding areas.

    NIH research University of Louisville · Louisville, United States · NIH-11523167

  • Rac-enhanced CAR-Macrophages against TNBC

    A new cell therapy approach uses engineered macrophages with a CAR and Rac2 activation to target and kill triple-negative breast cancer cells expressing CSPG4.

    NIH research University of Louisville · Louisville, United States · NIH-11520503

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.